Cargando…
Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
OBJECTIVE: To evaluate the impact of preoperative MRI in the management of Ductal carcinoma in situ (DCIS). METHODS: We searched the PubMed, EMBASE and Cochrane Library databases to identify randomised clinical trials (RCTs) or cohort studies assessing the impact of preoperative breast MRI in surgic...
Autores principales: | Canelo-Aybar, Carlos, Taype-Rondan, Alvaro, Zafra-Tanaka, Jessica Hanae, Rigau, David, Graewingholt, Axel, Lebeau, Annette, Pérez Gómez, Elsa, Rossi, Paolo Giorgi, Langendam, Miranda, Posso, Margarita, Parmelli, Elena, Saz-Parkinson, Zuleika, Alonso-Coello, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270803/ https://www.ncbi.nlm.nih.gov/pubmed/34052881 http://dx.doi.org/10.1007/s00330-021-07873-2 |
Ejemplares similares
-
Correction to: Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
por: Canelo-Aybar, Carlos, et al.
Publicado: (2022) -
Digital breast tomosynthesis compared to diagnostic mammographic projections (including magnification) among women recalled at screening mammography: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
por: Canelo‐Aybar, Carlos, et al.
Publicado: (2021) -
Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
por: Canelo-Aybar, Carlos, et al.
Publicado: (2021) -
Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative
por: Giorgi Rossi, Paolo, et al.
Publicado: (2021) -
Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review
por: Niño de Guzmán, Ena, et al.
Publicado: (2020)